Gene Expression Profiling of Structural and Functional High-Risk Multiple Myeloma

被引：0
|
作者：
Binder, Moritz [1 ]
Rajkumar, S. Vincent [1 ]
Lacy, Martha Q. [1 ]
Haug, Jessica L. [1 ]
Dispenzieri, Angela [1 ]
Henderson, Kimberly J. [1 ]
Kimlinger, Teresa K. [1 ]
Stewart, A. Keith [2 ]
Bergsagel, P. Leif [2 ]
Kumar, Shaji K. [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Mayo Clin, Div Hematol, Scottsdale, AZ USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-124637
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3061
引用
收藏
页数：3
相关论文
共 50 条
  • [1] High-Risk Multiple Myeloma Patients Are Missed without Gene Expression Profiling
    Van Vliet, Martin H.
    Chen, Yan-Ting
    Van Beers, Erik H.
    Kuiper, Rowan
    Valent, Erik T.
    Spaan, Marieke
    Terragna, Carolina
    Zamagni, Elena
    Cavo, Michele
    Oliva, Stefania
    Larocca, Alessandra
    Haferlach, Torsten
    Chng, Wee-Joo
    Waage, Anders
    Duin, M.
    Sonneveld, Pieter
    BLOOD, 2020, 136
  • [2] A gene expression signature for high-risk multiple myeloma
    R Kuiper
    A Broyl
    Y de Knegt
    M H van Vliet
    E H van Beers
    B van der Holt
    L el Jarari
    G Mulligan
    W Gregory
    G Morgan
    H Goldschmidt
    H M Lokhorst
    M van Duin
    P Sonneveld
    Leukemia, 2012, 26 : 2406 - 2413
  • [3] A gene expression signature for high-risk multiple myeloma
    Kuiper, R.
    Broyl, A.
    de Knegt, Y.
    van Vliet, M. H.
    van Beers, E. H.
    van der Holt, B.
    el Jarari, L.
    Mulligan, G.
    Gregory, W.
    Morgan, G.
    Goldschmidt, H.
    Lokhorst, H. M.
    van Duin, M.
    Sonneveld, P.
    LEUKEMIA, 2012, 26 (11) : 2406 - 2413
  • [4] Erratum: A gene expression signature for high-risk multiple myeloma
    R Kuiper
    A Broyl
    Y de Knegt
    M H van Vliet
    E H van Beers
    B van der Holt
    L el Jarari
    G Mulligan
    W Gregory
    G Morgan
    H Goldschmidt
    H M Lokhorst
    M van Duin
    P Sonneveld
    Leukemia, 2014, 28 : 1178 - 1180
  • [5] Benefit of complete response in multiple myeloma limited to high-risk subgroup identified by gene expression profiling
    Haessler, Jeffrey
    Shaughnessy, John D., Jr.
    Zhan, Fenghuang
    Crowley, John
    Epstein, Joshua
    van Rhee, Frits
    Anaissie, Elias
    Pineda-Roman, Mauricio
    Zangari, Maurizio
    Hollmig, Klaus
    Mohiuddin, Abid
    Alsayed, Yazan
    Hoering, Antje
    Tricot, Guido
    Barlogie, Bart
    CLINICAL CANCER RESEARCH, 2007, 13 (23) : 7073 - 7079
  • [6] Total Therapy (TT) Studies For Gene Expression Profiling (GEP)-Defined High-Risk Multiple Myeloma
    Heuck, Christoph
    van Rhee, Frits
    Mitchell, Alan
    Rosenthal, Adam
    Waheed, Sarah
    Petty, Nathan M.
    Bailey, Clyde
    Williams, Ryan
    van Laar, Ryan
    Panozzo, Susan B.
    Sawyer, Jeffrey
    Crowley, John
    Barlogie, Bart
    BLOOD, 2013, 122 (21)
  • [7] Genomic profiling of treated high-risk smoldering multiple myeloma
    Diamond, Benjamin
    Kazandjian, Dickran
    Papadimitriou, Marios
    Ziccheddu, Bachisio
    Blaney, Patrick
    Chojnacka, Monika
    Durante, Michael
    Hill, Elizabeth
    Sklavenitis-Pistofidis, Romanos
    Davies, Faith
    Getz, Gad
    Ghobrial, Irene
    Morgan, Gareth
    Maura, Francesco
    Landgren, Ola
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S227 - S228
  • [8] Gene expression profiling (GEP) in multiple myeloma (MM): Distinguishing relapses with high-risk transformation from those with sustained low risk
    Sawyer, J.
    Shaughnessy, J. D.
    Haessler, J.
    Hoering, A.
    Barlogie, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Gene expression profiling and multiple myeloma
    Shaughnessy, J
    Zhan, FH
    Barlogie, B
    Stewart, AK
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (04) : 537 - 552
  • [10] Gene expression profiling of multiple myeloma
    Minvielle, S
    BULLETIN DU CANCER, 2003, 90 (02) : 127 - 130
12345